Fears over cancer risk with MS drug cladribine unfounded Cladribine was refused a licence for multiple sclerosis because of fears it increases the risk of cancer, but a new analysis finds no evidence to support this.…
Antidiabetic agent could smother pancreatic cancer stem cells Metformin, commonly used for diabetes, was found to shut down metabolism in pancreatic cancer stem cells, which can spread cancer around the body.…
Glaucoma treatment may counter the virulence of tuberculosis Researchers screened compounds that inhibit the way Mycobacterium tuberculosis adapts to its environment in a host.…
Antimalaria drugs could be an effective treatment for Parkinson’s disease Two antimalarials were found to activate a receptor in the brain that is involved in protecting neurons that are lost in Parkinson’s disease.…
Metformin does not improve pregnancy outcomes in obese women Researchers conducted a randomised controlled trial of metformin in pregnant obese women, but the drug did not reduce the birthweight of offspring or pregnancy complications.…
Methotrexate identified as potential treatment for blood cancers Researchers screened for drugs that inhibit metabolic pathway associated with myeloproliferative neoplasms.…
The secret life of ketamine Ketamine is being used to treat depression in clinics that are springing up across the United States, but uncertainty remains over its long-term use.…
